Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chong-xian Pan
Mp52-01 Combination of Indomethacin and Enzalutamide to Treat Castration-Resistant Prostate Cancer
Journal of Urology
Urology
Human Microdosing for the Prediction of Patient Response
Bioanalysis
Pharmacology
Analytical Chemistry
Medical Laboratory Technology
Clinical Biochemistry
Medicine
Toxicology
Pharmaceutics
Related publications
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
Clinical Medicine Insights: Oncology
Oncology
Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer
Japanese Journal of Urology
Urology
A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer
PLoS ONE
Multidisciplinary
Mp52-11 Association of Dose Reduction of Abiraterone Acetate Plus Prednisone or Enzalutamide and Psa Progression in Veterans With Metastatic Castration Resistant Prostate Cancer
Journal of Urology
Urology
Mp52-19 Impact of Enzalutamide on Pain and Health-Related Quality of Life in Men With Non-Metastatic Castration-Resistant Prostate Cancer: Prosper Study Results
Journal of Urology
Urology
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Plasma Levels of Enzalutamide and Its Main Metabolites in a Metastatic Castration-Resistant Prostate Cancer Patient Undergoing Hemodialysis
Clinical Genitourinary Cancer
Oncology
Urology
